Verified· 3 sources

Versameb AG

Summary

About the company

The core activity of Versameb is the development of therapeutic solutions, particularly in the fields of dermatology, oncology and mycology, based on a proprietary platform technology.

AI-generated

Offering

Products & services

Industry:Pharmaceutical Industry

✓ Offered7

RNA therapeutics

RNA-based therapeutics for targeted up- or downregulation of proteins, with applications in immunological disorders, oncology and myology.

VERSagile research and development platform

VERSagile platform for nucleotide therapies with the pillars Protein Secretion and Multi-protein target, for developing new molecules and therapeutic concepts.

Drug development for stress urinary incontinence

Development of a lead molecule in an advanced preclinical phase for the treatment of stress urinary incontinence, focusing on functional recovery and tissue regeneration.

Drug development for solid tumors

Development of RNA drug candidates to modulate the tumor microenvironment in solid tumors by simultaneously upregulating and suppressing multiple targets.

Drug development for immunological disorders

Development of RNA-based molecules to regulate the immune response in areas where immunomodulatory treatment approaches are needed.

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

Versameb AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

Versameb AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

Mentions & media

No knowledge articles yet

Versameb AG in comparison

Industry comparisons are coming soon

Similar companies